Vol 6, No 4 (April 01, 2014): Journal of Thoracic Disease (Hypo- and hyper-fractionated radiotherapy in NSCLC using cutting-edge technologies)

Review Article

Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy
Anish Prasanna, Mansoor M. Ahmed, Mohammed Mohiuddin, C. Norman Coleman
Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies
Carri K. Glide-Hurst, Indrin J. Chetty
Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities
Wouter van Elmpt, Catharina M.L. Zegers, Marco Das, Dirk De Ruysscher
Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
Kate Haslett, Christoph Pöttgen, Martin Stuschke, Corinne Faivre-Finn
Radiation dose effect in locally advanced non-small cell lung cancer
Feng-Ming (Spring) Kong, Jing Zhao, Jingbo Wang, Corrine Faivre-Finn
Accelerated dose escalation with proton beam therapy for non-small cell lung cancer
Daniel R. Gomez, Joe Y. Chang
Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC
Fiona McDonald, Sanjay Popat
New techniques for assessing response after hypofractionated radiotherapy for lung cancer
Sarah A. Mattonen, Kitty Huang, Aaron D. Ward, Suresh Senan, David A. Palma
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer
Joshua D. Palmer, Nicholas G. Zaorsky, Matthew Witek, Bo Lu

Original Article

Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung
Deepinder Singh, Yuhchyau Chen, Mary Z. Hare, Kenneth Y. Usuki, Hong Zhang, Thomas Lundquist, Neil Joyce, Michael C. Schell, Michael T. Milano


The focused issue “Hypo- and hyper-fractionated radiotherapy in NSCLC using cutting-edge technologies” was commissioned by the editorial office, Journal of Thoracic Disease without any sponsorship or funding. Joe Y. Chang and Dirk De Ruysscher served as the unpaid Guest Editors for the focused issue.